Verici Dx plc engages in developing and commercializing clinical diagnostics kidney transplant tests. The company was incorporated in 2020 and is based in Penarth, United Kingdom. As of July 10, 2020, Verici Dx plc is a former subsidiary of Renalytix AI plc. The company trades on AIM exchange marketplace. The company headquarter is located in Penarth, United Kingdom. The company was established in the 2020. The company's ISIN is GB00BM8HZD43.
TickerVRCI
Long NameVerici Dx plc
Short NameVerici Dx PLC
SectorHealthcare
SubsectorDiagnostics & Research
Subsector 2
CurrencyGBX
ISINGB00BM8HZD43